Phosprenyl: A novel drug with antiviral and immunomodulatory activity

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 5-6, 1996, Pages 395-400

  Danilov, Leonid L ^a   Maltsev, Sergey D ^a   Deyeva, Anna V ^a   Narovlyansky, Alexander N ^a   Sanin, Alexander V ^a   Ozherelkov, Sergey V ^a   Pronin, Alexander V ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Phosprenyl; polyprenyl phosphates; treatment of viral diseases

Indexed keywords

ANTIVIRUS AGENT; PHOSPRENYL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; DOG; DOG DISEASE; ENTERITIS; HAMSTER; HEPATITIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MOUSE; NONHUMAN; RABIES; SHORT SURVEY; TICK BORNE ENCEPHALITIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIVIRAL AGENTS; CLINICAL TRIALS; CRICETINAE; DISTEMPER; DOG DISEASES; DOGS; DOLICHOL PHOSPHATES; DRUG EVALUATION, PRECLINICAL; ENTERITIS; HEPATITIS, VIRAL, ANIMAL; MICE; MOLECULAR STRUCTURE; PARVOVIRIDAE INFECTIONS; POLYISOPRENYL PHOSPHATES; RATS; VIRUS DISEASES;

EID: 0029801571     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. ALONSO-ROMANOVSKI S., FELIZ M. R., BELOCOPITOW E. and DISALVO E. A. (1988): Effect of dolichyl monophosphate on the permeability properties of lipid membranes. Biochim. Biophys. Acta, 946, 389-396.
2. BUGG T. D. H. and BRANDISH P. E. (1994): From peptidoglycan to glycoproteins: common features of lipid-linked oligosaccharide biosynthesis. FEMS Microbiol. Lett., 119, 255-262.
3. CHOJNACKI T. and DALLNER G. (1988): The biological role of dolichol. Biochem. J., 251, 1-9.
4. DANILOV L. L. and SHIBAEV V. N. (1991): Phosphopolyprenols and their glycosyl esters: chemical synthesis and biochemical application. In ATTA-UR-RAHMAN (ed.): Studies in natural products chemistry. Elsevier, Amsterdam - Oxford-New York - Tokyo, 8, 63-114.
5. HEMMING F. W. (1985): Glycosyl phosphopolyprenols. In WIEGANDT H. (ed.): New comprehensive biochemistry. Glycolipids. Elsevier, Amsterdam - New York - Oxford, 10, 261-305.
6. OKAMOTO Y., TAHARA Y. and MISHIMA Y. (1990): Polyprenols and polyprenyl phosphates for inhibition of tumour metastasis. Eur. Pat. Appl. EP 0 350 801 A2.
7. RIP J. W., RUPAR C. A., RAVI K. and CAROLL K. K. (1985): Distribution, metabolism and function of dolichol and polyprenols. Progr. Lipid Res., 24, 269-309.
8. SANIN A. V., DANILOV L. L., MALTSEV S. D., KUZINA T., LYSYUK O. G., NAROVLYANSKY A. N., MISURENKO N. K. and YEVSTROPOVA I. (1992): Inhibition of HIV-1 in vitro infectivity by a P16 substance with a potent antiviral activity. In Published abstracts and indices. VIII Int. Conf. on AIDS Amsterdam, 3, 35 (PuA 6149).
9. SANIN A. V., DANILOV L. L., NAROVLYANSKY A. N., MALTSEV S. D., MOISEENKOV A. M., PROZOROVSKY S. V., SHIBAEV V. N., VESELOVSKY V. V., NASTASHENKO T. A. and MISURENKO N. K. (1994): Antiviral drug. Rus. Pat. Appl. RU 2005475 C1.
10. SHIRANE K., FURUKAWA K., FUKUCHI K., YAMAZAKI H., TSUJI M. and OKAMOTO Y. (1995): Effects of N-3554S, a polyprenyl phosphate, on B16-F10 mouse melanoma cells. Biochim. Biophys. Acta, 1286, 285-292.
11. TAKAK F., URABE A., SHIMAMURA M. and MIZUKO M. (1986): Use of dolichol or its esters in medicines. Eur. Pat. Appl. EP 0 166 436 A2.
12. WEISSBORN A. C., RUMLEY M. K. and KENNEDY E. P. (1991): Biosynthesis of membrane-derived oligosaccharides. Membrane-bound glycosyl-transferase system from E. coli requires polyprenyl phosphate. J. Biol. Chem., 266, 8062-8067.
13. YAMATSU I., SUZUKI T., ABE S., NAKAMOTO K., KAJIAWARA A., KATAYAMA K., TSUNODA H., MURAKAMI M., ONO H. and YAMADA K. (1985): Therapeutic and preventive agent containing dolichol. Eur. Pat. Appl. EP 0 149 847 A2.